Cargando…

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

SIMPLE SUMMARY: The search for serum biomarkers of inflammatory activity in patients with immune-mediated diseases is an area of interest and has been the subject of multiple investigations in recent years. Calprotectin is a biomarker that can be used to identify inflammation and tissue damage and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frade-Sosa, Beatriz, Chacur, Chafik Alejandro, Augé, Josep M., Ponce, Andrés, Sarmiento-Monroy, Juan C., Azuaga, Ana Belén, Sapena, Nuria, Ramírez, Julio, Ruiz-Esquide, Virginia, Morlà, Rosa, Farietta, Sandra, Corzo, Patricia, Cañete, Juan D., Sanmartí, Raimon, Gómez-Puerta, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251936/ https://www.ncbi.nlm.nih.gov/pubmed/37296947 http://dx.doi.org/10.3390/cancers15112984

Ejemplares similares

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
por: Ponce, Andrés, et al.
Publicado: (2022)

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022)

Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?
por: Sanmartí, Raimon, et al.
Publicado: (2021)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity
por: Inciarte-Mundo, José, et al.
Publicado: (2016)

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study
por: Inciarte-Mundo, José, et al.
Publicado: (2018)

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
por: Cabrera-Villalba, Sonia, et al.
Publicado: (2017)

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
por: Gómez-Puerta, José A, et al.
Publicado: (2013)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission
por: Ramírez, Julio, et al.
Publicado: (2016)

Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
por: Chen, Shyi-Jou, et al.
Publicado: (2012)

Vaccines – beliefs and concerns: the voice of patients with inflammatory immunomediated diseases
por: Abreu, Cândida, et al.
Publicado: (2023)

Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers
por: Ramírez, Julio, et al.
Publicado: (2014)

COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments
por: Soldevila-Domenech, Natalia, et al.
Publicado: (2020)

Immunomediated Sequential Dissection of Visceral Arteries: Dramatic Improvement After Steroid Therapy
por: Pina, Alessandra, et al.
Publicado: (2022)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis
por: Cuervo, Andrea, et al.
Publicado: (2021)

Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation
por: El Baroudi, Mariama, et al.
Publicado: (2016)

Descriptive study of patients with uveitis attended during one-year period - diagnostic classification and treatment
por: Hernández, M V, et al.
Publicado: (2010)

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis
por: Julià, Antonio, et al.
Publicado: (2020)

Synovial lymphoid neogenesis is associated with IL-23 expression and disease activity in rheumatoid arthritis
por: Cañete, Juan D, et al.
Publicado: (2011)

Anticitrullinated peptide antibodies (ACPA) in the serum of heavy smokers without arthritis - a differential role of associated pulmonary disease?
por: Ruiz-Esquide, V, et al.
Publicado: (2010)

Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
por: Cañete, Juan D, et al.
Publicado: (2009)

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
por: Azuaga, Ana Belén, et al.
Publicado: (2023)

The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis
por: de la Calle-Fabregat, Carlos, et al.
Publicado: (2022)

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
por: Moreno, Mireia, et al.
Publicado: (2019)

Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study
por: Gómez-Puerta, José A., et al.
Publicado: (2022)

Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
por: Tudoran, Oana, et al.
Publicado: (2015)

Impact of Exercise Intensity on Calprotectin Levels in Healthy Volunteers and Patients with Inflammatory Rheumatic Diseases
por: Xavier, Andy, et al.
Publicado: (2021)

Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
por: Izquierdo, Elena, et al.
Publicado: (2009)

Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression
por: Rodriguez-Martinez, Lorena, et al.
Publicado: (2023)

Update on Cardiovascular Risk and Obesity in Psoriatic Arthritis
por: Ramírez, Julio, et al.
Publicado: (2021)

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
por: Sanmartí, Raimon, et al.
Publicado: (2009)

Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
por: Celis, Raquel, et al.
Publicado: (2012)

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
por: Sanmartí, Raimon, et al.
Publicado: (2023)

Designing Studies for Epigenetic Biomarker Development in Autoimmune Rheumatic Diseases
por: de la Calle-Fabregat, Carlos, et al.
Publicado: (2022)

Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
por: Lubrano, Ennio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mc6vcfn75isr5dkbmqmglp97mb